Mast Cells Are a Marked Source for Complement C3 Products That Associate with Increased CD11b-Positive Cells in Keratinocyte Skin Carcinomas

Cancer Invest. 2019;37(2):73-84. doi: 10.1080/07357907.2019.1565765. Epub 2019 Jan 28.

Abstract

By using immunohistochemistry and antibodies that identify complement C3c (in C3 and C3b) or CD11b receptor, we report that the proportion C3c+ mast cells and the number of CD11b+ cells are increased in basal cell carcinoma (BCC). Instead, only CD11b+ cells are increased in squamous cell carcinoma/Bowen's disease, and only slightly so in actinic keratosis. Only C3c+ mast cells are increased in psoriasis. Furthermore, C3c+ mast cells correlated positively with CD11b+ cells, and iC3b immunoreactivity was detected around tryptase+ mast cells. Therefore, mast cells may convey immunoregulatory signals through C3, C3b, and iC3b to CD11b+ cells, especially in BCC.

Keywords: Actinic keratosis; Basal cell carcinoma; C3; CD11b; Mast cell; Psoriasis; Squamous cell carcinoma.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biopsy
  • Bowen's Disease / metabolism
  • CD11b Antigen / metabolism*
  • Carcinoma, Basal Cell / metabolism
  • Carcinoma, Squamous Cell / metabolism
  • Complement C3 / metabolism*
  • Female
  • Humans
  • Keratinocytes / metabolism*
  • Male
  • Mast Cells / metabolism*
  • Middle Aged
  • Psoriasis / metabolism
  • Skin / metabolism
  • Skin Neoplasms / metabolism*

Substances

  • CD11b Antigen
  • Complement C3
  • ITGAM protein, human